Current AusVaxSafety surveillance data
Last updated 13 April 2018
INFLUENZA VACCINE SAFETY DATA
Surveillance of 2018 influenza vaccine safety commenced from 1 April 2018.
HPV VACCINE ACTIVE SURVEILLANCE DATA
From January 2018 a new HPV vaccine, Gardasil®9, is being funded under the National Immunisation Program. AusVaxSafety is monitoring the safety of HPV vaccine in 11-14 year olds. Injection site reactions, including pain, are known to occur following administration of HPV vaccines, and the current reported event rates are consistent with what are expected according to the existing data.
ZOSTER (SHINGLES) VACCINE SAFETY DATA
There is currently a low rate of events and medical attendance following zoster vaccine, which is consistent with the existing knowledge of the vaccine safety profile.
It is important to re-emphasise that zoster vaccine should not be given to immunocompromised individuals. For more information please refer to the Therapeutic Goods Administration (TGA) website.
PERTUSSIS (WHOOPING COUGH) VACCINE SAFETY DATA
Injection site reactions are known to occur following administration of acellular pertussis vaccines. The current reported event rates are consistent with existing data on pertussis vaccines.